Approval for a new programmer device. the device, as modified, will bemarketed under the trade name prometra programmable infusion pump system and is indicated for intrathecal infusion of infumorph (preservative-free morphine sulfate) or preservative-free sterile 0.9% saline solution (sodium chloride injection, usp).